30 results about "Low-protein diet" patented technology

The invention discloses a production method for low-protein noodles. The production method comprises the following steps of: A, uniformly mixing starch with the protein content less than 0.5% with water according to a mass ratio of 1 to (0.2 to 0.3), and stirring for 20-30 minutes to prepare starch paste; B, adding the starch paste prepared in the step A into a noodle extrusion machine, and extruding noodles at the temperature of 80-85 DEG C under the pressure of 2.5-3.0MPa at a mould outlet of the extrusion machine; C, drying the noodles prepared in the step B until the water content is lower than 0.08%; D, cutting and packaging the dried noodles in the step C. The production method has the beneficial effects that low-protein diet crowd can enjoy daily staple foods without ingesting proteins in original similar foods; the low-protein noodles are convenient and delicious, and fit original staple food habits; the requirements of the crowd on a healthy diet and a delicious diet are met; meanwhile, the noodles cannot be gelatinized when being boiled in water.

[Problem] To provide a compound useful as a drug for preventing and / or treating kidney disease. [Solution] The inventors studied compounds having trypsin-inhibiting activity, confirmed that guanidinobenzoic acid ester compounds have trypsin-inhibiting activity, and completed the invention. These guanidinobenzoic acid ester compounds can be used as drugs for the prevention and / or treatment of kidney disease (for example, chronic kidney disease, acute glomerulonephritis, acute renal failure, and the like) as alternative drugs to a low-protein diet, and / or as drugs for the prevention and / or treatment of diseases in which trypsin participates (for example, chronic pancreatitis, reflux esophagitis, hepatic encephalopathy, influenza, and the like).

The invention belongs to the field of nephrology, and relates to a chronic kidney disease angiosteosis experiment model and a making method thereof. The chronic kidney disease angiosteosis experiment model is established by using C57BL / 6 mouse molding through cooperation of combination of adenine and vitamin D with a high-phosphorus and low-protein diet intervention mode. The making method has the advantages of short modeling time and good stability; and the established chronic kidney disease angiosteosis experiment model can be further used to screen drugs for treating chronic kidney disease angiosteosis and research mechanisms of the drugs.

The invention discloses low-protein nutrition crisp slices and a making method thereof. The low-protein nutrition crisp slices comprise, by weight, 90-95 parts of edible starch, 0.5-10 parts of cane sugar, 0.5-3 parts of malt extract, 0.5-2 parts of salt, 0.2-0.8 part of monostearin and 0.2-0.8 part of double-effect baking powder. The low-protein nutrition crisp slices are made by using the edible starch as a major ingredient and using cane sugar, malt extract, salt, monostearin, double-effect baking powder and the like as auxiliary materials and are nutritious, crispy and tasty and easy to digest and absorb. The low-protein nutrition crisp slices can be used as staple food at breakfast, can also be used as daily snack food, can control protein intake of nephrotic patients and phenyketonuria (PKU) patients, provide sufficient heat for the patients, and help the patients to develop a habit of eating low-protein food. By limiting the intake of the protein, diseases are prevented, and the low-protein nutrition crisp slices are ideal breakfast and snack food for the PKU patients and the nephrotic patients.

The present invention provides methods for treating and preventing the reoccurrence of C. diff infection by administering an immunoglobulin concentrate in conjunction with a low protein diet.

A Chinese medicine in the form of orally taken solid for treating fatty liver and fatty hepatitis is prepared from 5 Chinese-medicinal materials including oriental wormwood, giant knotwood rhizome, turmeric, capejasmine fruit, etc. Its preparing process is also disclosed.

The present invention provides compounds useful as prophylactic and / or therapeutic agents for renal diseases. The present inventors conducted research on compounds having trypsin inhibitory activity, confirmed that guanidinobenzoic acid compounds have trypsin inhibitory activity, and completed the present invention. The guanidinobenzoic acid compound of the present invention can be used as a prophylactic and / or therapeutic agent for kidney disease as an alternative to low-protein diet therapy, and trypsin-related diseases such as pancreatitis, reflux esophagitis, hepatic encephalopathy, Preventive and / or therapeutic agent for influenza etc.

The invention relates to low-protein biological feeds, which comprise the following components in parts by weight: 72 to 85 parts of corns, 6 to 18 parts of soybean meal, 3 to 6 parts of wheat bran, 0 to 1.5 parts of soybean oil, 0.4 to 0.8 part of limestone, 0.5 to 1.5 parts of calcium hydrogen phosphate, 0.3 to 0.6 part of table salt, 0.6 part of premix, 1 part of compound microecological preparation, 0.2 to 0.6 part of L-lysine, 0.05 to 0.12 part of DL-methionine, 0.03 to 0.08 part of L-tryptophan and 0.08 to 0.13 part of L-threonine, wherein the compound microecological preparation comprises butyric acid bacteria, fermentative lactobacillus and bacillus subtilis. According to the low-protein biological feeds, the utilization rate of a nitrogen source in animal feeds can be remarkably increased, the emission of the nitrogen source is reduced, the growth performance of animals can be improved, and remarkable technical effects are achieved.

The invention belongs to the field of pig feed, and specifically relates to a drug-free feed for growing and fattening pigs. The feed includes the following components per 1000 kg: 997.7-999.4 kg of low-protein diet, 0.1-0.8 kg of enzyme preparation and probiotics- Functional oligosaccharide composition 0.5-1.5kg, wherein: the low-protein diet should meet: make the protein content of the feed≤15.0%, and the enzyme preparation contains xylanase, mannanase and fiber Sulfase, the probiotic-functional oligosaccharide composition consists of Bacillus subtilis, Clostridium butyricum, Bacillus licheniformis and chitosan oligosaccharide. The invention solves the problem of using antibiotic drugs in the feed, starts from the utilization of raw materials and the health of intestinal flora, obtains good growth performance effects, and brings better benefits to farmers.

The invention discloses a feed additive for improving milk yield and milk quality of a lactating sow and a preparation method of the feed additive, and belongs to the field of feed additives. The additive is composed of the following raw materials in parts by weight: 5-15 parts of soybean meal powder, 13-26 parts of Chinese medicinal herbal compound, 2-4 parts of xylooligosaccharide, 2.5-4.5 partsof bifidobacterium triple viable suspension, 2.5-4.5 parts of lactobacillus fermenti suspension, and 60 parts of water. The additive can effectively improve milk yield and milk quality of a lactatingsow by combining with a low protein diet while reducing nitrogen content in pig manure and ammonia concentration in a pig house, and improving the environment of a pig farm. The feed additive uses safe raw materials, is free of side effects, and has no pollution to the environment.

The invention relate to a pregnant sow low protein daily feed formula, belonging to the animal feed field. The pregnant sow low protein daily feed formula provided in the invention can reduce production cost, maintain or increase the growth performance of the pregnant sow, to solve the problems existing in the current technologies. The invention increases the raw material utilization rate of pregnant sow, meets the needs of pregnant sow by reducing the soybean meal content in daily feed and supplementing some artificial synthesized essential amino acids, while maintains the production performance constant, and improves feed conversion rate, livestock and poultry nitrogen deposition and nitrogen discharge, and heat stress capability.

The present invention provides a compound useful as a prophylactic and / or therapeutic agent for nephropathy. The inventors of the present invention conducted research on compounds having trypsin inhibitory activity, confirmed that guanidinobenzoate compounds have trypsin inhibitory activity, and completed the present invention. The guanidine benzoate compound of the present invention can be used as a preventive and / or therapeutic agent for renal disease (for example, chronic kidney disease, acute glomerulonephritis, acute kidney injury, etc.) Use as a prophylactic and / or therapeutic agent for diseases in which proteases are involved (for example, chronic pancreatitis, reflux esophagitis, hepatic encephalopathy, influenza, etc.).

The invention discloses a compound alpha-keto acid dispersible tablet for treating chronic kidney diseases, containing four kinds of keto amino acid calcium, one kind of hydroxyamino acid calcium, five kinds of amino acid and pharmaceutically acceptable adjuvants. The tablet is mainly and clinically used for postponing renal failure process, correcting metabolic disturbance, coordinating with low-protein diet and preventing and treating damages caused by protein metabolism disorder because of chronic renal insufficiency.

The present invention discloses a nutritional composition for non-dialysis patients and the nutritional composition includes the following raw material components in parts by weight: 90-120 parts of maltodextrin, 70-80 parts of potato powder, 30-35 parts of fructose, 9-16 parts of whey protein, 12-18 parts of walnut oil, 4-6 parts of medium-chain triglycerides, 3-4 parts of red beet powder, 0.1-0.3 part of compound vitamins, and 0.1-0.3 part of compound minerals. The nutritional composition provides non-dialysis patients with parts of nutrition, reaches the purpose of conducting nutrition intervention for non-dialysis patients by combining with low protein diet, improves and even inhibits disease development, and improves the life quality of patients.

The invention relates to low protein sorghum noodles special for patients suffering diabetes or nephropathy and a preparation method of the low protein sorghum noodles, and belongs to the technical field of agro-product processing. The low protein sorghum noodles comprise the following raw materials: 20-30 parts of sorghum flour, 10-15 parts of wheat flour, 10-15 parts of chickpea powder, 30-60 parts of wheat starch, 10-20 parts of pre-gelatinized starch, 0.8-1.2 parts of a thickening agent, 0.1-0.3 part of composite phosphate, 0.3-0.5 part of table salt, 0.1-0.3 part of carbonate, 0.1-0.3 part of edible alcohol, and 0.1-0.3 part of carboxymethyl cellulose calcium. The sorghum noodles prepared by the method disclosed by the invention increase the variety of low protein staple foods, richen the food and the drink of the patients suffering from the diabetes and the nephropathy, can meet the requirements of the patients suffering from the diabetes and the nephropathy for a low protein diet, are high in absorption and utilization rate, and are long in quality guarantee period. Semi-finished flour products are prepared under different temperatures, so that the toughness and the ductility of the semi-finished flour products can be improved, and the sensing quality of the prepared noodles is good.